José F. Fernandes

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 404 citations · Full text

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Angela Huttner, Sélidji Todagbé Agnandji, Christophe Combescure et al. · The Lancet Infectious Diseases · 2018 · 79 citations · Full text

Vaccination, Single-dose Rvsv-zebov Vaccination, Antibody Persistence +7

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

Sélidji Todagbé Agnandji, José F. Fernandes, Emmanuel B. Bache et al. · PLoS Medicine · 2017 · 68 citations · Full text

Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees

Gemma Moncunill, Maxmillian Mpina, Augusto Nhabomba et al. · Clinical Infectious Diseases · 2017 · 35 citations · Full text

Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative

Jacqueline Kyungah Lim, Mabel Carabalí, Jung-Seok Lee et al. · BMJ Open · 2018 · 34 citations · Full text